Type 2 Diabetes Treatment





Type 2 Diabetes Treatment


Type 2 Diabetes Treatment

Oral Medications:

Sulfonylurea (SU)

  • Mechanism:
  • Stimulates insulin secretion from the pancreas.
  • Prevents insulin breakdown.
  • Classification:
  • First generation (SU1): Tobutamid, Carbartamid, Clopropamid.
  • Second generation (SU2): Gli…
  • Side effects:
  • Hypoglycemia, disulfiram-like reaction, agranulocytosis, hepatitis.
  • Indications:
  • Non-obese patients with type 2 diabetes.
  • Take 30 minutes before meals.

Glinide

  • Medications: Nateglinide, Repaglinide.
  • Mechanism: Stimulates insulin secretion from the pancreas.
  • Indications: Patients with type 2 diabetes, use after meals, can be taken with food.
  • Side effects: Milder than SU.

Biguanide

  • Medication: Metformin.
  • Mechanism:
  • Activates AMPK, increases insulin activity in cells.
  • Only effective in the presence of endogenous insulin.
  • Indications: Obese patients with type 2 diabetes.
  • Side effects:
  • Lactic acidosis.
  • Metallic taste.
  • Reduced absorption of vitamin B12, B9.

Thiazolidinediones (TZD)

  • Medication: Pioglitazone.
  • Mechanism:
  • Activates PPAR gamma receptors.
  • Increases insulin sensitivity.
  • Side effects:
  • Weight gain.
  • Liver toxicity.
  • Edema.
  • Osteoporosis.

Alpha-glucosidase Inhibitors:

  • Medication: Acarbose.
  • Mechanism: Inhibits alpha-glucosidase enzyme, slowing down sugar absorption in the gut.
  • Indications: Take after meals.

Injectable Medications:

DPP-4 Inhibitors:

  • Medications: …liptin.
  • Mechanism: Inhibits DPP-4 enzyme, increasing endogenous GLP-1 levels.
  • Side effects:
  • Mild weight loss.
  • Pancreatitis.

GLP-1 Analogs:

  • Medication: Exenatide.
  • Mechanism: Similar to endogenous GLP-1, binds and activates GLP-1 receptors.
  • Indications: Patients with type 2 diabetes.
  • Administration: Subcutaneous injection twice daily.

Amylin Analogs:

  • Medication: Pramlintide.
  • Mechanism: Derivative of amylin, helps slow digestion and insulin secretion.
  • Indications: More common in patients with type 1 diabetes.
  • Administration: Subcutaneous injection.

Note: This information is for general knowledge only. Please consult your doctor before using any medications.



Leave a Reply

Your email address will not be published. Required fields are marked *